CML Lung Cancer

» Advanced search

Paper of the Month - October, 2011

• View Archive »

  • Computed tomography appearance of early radiation injury to the lung: correlation with clinical and dosimetric factors. - March, 2012
    Randomized Phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small cell lung cancer. - February, 2012
    Survival after resection of synchronous non-small cell lung cancer. - January, 2012
    Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. - September, 2011
    Assessment of lung-cancer mortality reduction from CT screening. - August, 2011
    Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. - July, 2011
    Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. - June, 2011
    Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. - May, 2011
    Chemotherapy with cetuximab or chemotherapy alone for untreated advanced non-small-cell lung cancer: a systematic review and meta-analysis. - April, 2011
    High rates of tumour growth and disease progression detected on serial pre-treatment fluorodeoxyglucose-positron emission tomography/CT scans in radical radiotherapy candidates with non small cell lung cancer. - March, 2011
    Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised Phase III trial (AVAIL). - February, 2011
    Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, Phase III trial. - January, 2011
    Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? - October, 2011
    Impact of neoadjuvant chemo-radiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer. - November, 2011
    Randomized Phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial. - December, 2011
    Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. - December, 2010
    A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. - November, 2010
    Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. - October, 2010
    A randomized, Phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer. - September, 2010
    Stereotactic radiosurgery for the treatment of lung neoplasm: experience in 100 consecutive patients. - August, 2010
    Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, Phase 3 study. - July, 2010
    Outcome in a prospective Phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. - June, 2010
    Preoperative staging of lung cancer with combined PET-CT. - May, 2010
    Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. - April, 2010
    Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. - March, 2010
    Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. - February, 2010
    Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a Phase III randomised controlled trial. - January, 2010
    Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. - December, 2009
    Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised Phase III trial. - November, 2009
    Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. - October, 2009
    Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. - September, 2009
    Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. - August, 2009
    Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, Phase III study. - July, 2009
    Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. - June, 2009
    Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy. - May, 2009
    Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized Phase III trial. - April, 2009
    Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. - March, 2009
    A Phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. - February, 2009
    Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients. - January, 2009